SUN PHARMA RAISES THE HEAT ON TARO
SUN Pharmaceutical Industries, the country's most valuable drugmaker, has decided to launch a hostile bid for Israel's Taro Pharmaceutical Industries. This is a rare instance of an Indian company making an unsolicited bid for a foreign firm. The move follows Taro's rejection of a merger agreement with Sun last month. Taro had termed the offer